Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Imprimis Phar Cmn (NASDAQ: IMMY)

$4.31 USD -$0.04 (-0.92%)
Last Price $4.31
Net Change $-0.04 (-0.92%)
Bid $4.03
Ask Price $4.38
Open Price $4.39
Previous Close Price $4.35
High Price $4.49
Low Price $4.22
Number of Trades 268
Volume 143,109
Fifty Two Week High $4.69 (2017-03-29)
Fifty Two Week Low $1.65 (2016-12-21)
Average Daily Volume 206,263
Share Outstanding 18,630 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $60.67
Recent Earnings $
Annual EPS $-1.51
Last Quarter EPS $
Market Capitalization $0.08B
Insider Shareholders % 0.1459%
Annual Revenue $0B
No. Shares Outstanding 18,630
Inst. Shareholder % 15.97%
Annual Net Income $0B
TTM Net Profit Margin $100.3
1-Year Return 11.54%
3-Year Return -40.9%
5-Year Return 2.35%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 60.669998%
Dividends per Share $
Stock Split Ratio 1-5
Beta 0.43
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company focused on its proprietary ophthalmology and urology drug formulations. Imprimis recently launched its urology business, which includes a patented formulation to address patients suffering from interstitial cystitis.